InvestorsHub Logo
icon url

Mellowmood77

11/02/19 9:19 PM

#222493 RE: Will Lar #222474

How is EPANOVA success good to Vascepa and Amarin?

Can you or someone elaborate on this? As I don’t see it.



If successful, but not as successful as reduce-it, it is further evidence that EPA works.

Now you have another CVOT that proves EPA extends your life with a different placebo.

Which drug would you rather take? A laxative that doesn't work as well? Or Vascepa?

icon url

BioChica

11/04/19 6:40 AM

#222636 RE: Will Lar #222474

If it reduces CV Risk, that's a good thing it validates EPA treatment for CVD, even if it accomplishes 15% Reduction. The placebo is another matter.

P.S. They will not be sell this drug in the U.S., patent protection stopped EPANOVA drug sales in the U.S.